SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-223590
Filing Date
2023-08-29
Accepted
2023-08-29 14:33:00
Documents
13
Period of Report
2023-08-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d878120d8k.htm   iXBRL 8-K 30259
2 EX-3.1 d878120dex31.htm EX-3.1 88221
  Complete submission text file 0001193125-23-223590.txt   259151

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA form10-20230823.xsd EX-101.SCH 2884
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE form10-20230823_lab.xml EX-101.LAB 15944
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE form10-20230823_pre.xml EX-101.PRE 10010
7 EXTRACTED XBRL INSTANCE DOCUMENT d878120d8k_htm.xml XML 3101
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 231221250
SIC: 2834 Pharmaceutical Preparations